Skip to content
S2537Senate2021-2022 SessionSame asA3927

Broaden Epinephrine Injector Access

Official title

“Relates to epinephrine injector device”

Sponsor Gustavo RiveraSD-33Affects Health
Status
In Senate Committee
Health
Impact
3/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill broadens the law to allow for the use of all epinephrine injector devices, not just auto-injectors, in emergency anaphylactic situations.

Why it matters

  1. Expands access to life-saving treatment. By allowing the use of all FDA-approved epinephrine injector devices, not just auto-injectors, the bill increases the range of emergency tools available to treat severe allergic reactions (anaphylaxis), which can be critical in situations where specific device types are unavailable.

  2. Updates training and protocols. Eligible individuals and organizations will now need training to use a broader variety of epinephrine injectors, which may include manual syringes or newer devices, ensuring first responders and laypersons are prepared for different device types.

  3. May reduce costs and improve supply. Auto-injectors are often more expensive and subject to shortages. Allowing other injector types could make emergency epinephrine more affordable and accessible, especially in schools, camps, and public venues.

  4. Clarifies legal protections and responsibilities. The law maintains liability protections and clarifies that using any approved injector device in emergencies does not constitute unauthorized medical practice, helping reduce hesitancy among non-medical personnel to respond quickly in life-threatening situations.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Broaden Epinephrine Injector Access

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3927Assembly

Update Epinephrine Injector Law

In Assembly Committee · Health · Sponsor Thomas Abinanti

Impact 3 · Low0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

2537

2021-2022 Regular Sessions

IN SENATE

January 21, 2021

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to epinephrine injector devices

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 3000-c of the public health law, as amended by chapter 373 of the laws of 2016, paragraph (a) of subdivision 1 as amended by chapter 633 of the laws of 2019, is amended to read as follows:

§ 3000-c. Epinephrine [auto-injector] injector devices. 1. Definitions. As used in this section:

(a) "Eligible person or entity" means: (i) an ambulance service or advanced life support first response service; a certified first responder, firefighter in a city, town or village having a population of less than one million, emergency medical technician, or advanced emergency medical technician, who is employed by or an enrolled member of any such service; (ii) a children's overnight camp as defined in subdivision one of section thirteen hundred ninety-two of this chapter, a summer day camp as defined in subdivision two of section thirteen hundred ninetytwo of this chapter, a traveling summer day camp as defined in subdivision three of section thirteen hundred ninety-two of this chapter or a person employed by such a camp; (iii) a school district, board of cooperative educational services, county vocational education and extension board, charter school, and non-public elementary and secondary school in this state or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; (iv) a sports, entertainment, amusement, education, government, day care or retail facility; an educational institution, youth organization or sports league; an establishment that serves food; or a person employed by such entity; (v) a police officer or peace officer in a city, town or

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01732-01-1

S. 2537 2

village having a population of less than one million; and (vi) any other person or entity designated or approved, or in a category designated or approved pursuant to regulations of the commissioner in consultation with other appropriate agencies.

(b) "Epinephrine [auto-injector] injector device" means a single-use device used for the [automatic] injection of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms approved by the food and drug administration.

(c) "Health care practitioner" means a health care practitioner licensed, certified, or authorized to practice under title eight of the education law who is authorized thereby to administer drugs, and who is acting within the scope of his or her practice.

2. Possession and use. (a) Any eligible person or entity may purchase, acquire, possess and use epinephrine [auto-injector] injector devices for emergency treatment of a person appearing to experience anaphylactic symptoms, under this section.

(b) An eligible person or entity shall designate one or more individuals who have completed the training required by paragraph (c) of this subdivision to be responsible for the storage, maintenance, control, and general oversight of the epinephrine [auto-injectors] injector acquired by the eligible person or entity.

(c) No one may use an epinephrine [auto-injector] injector device on behalf of an eligible person or entity unless he or she has successfully completed a training course in the use of epinephrine [auto-injector] injector devices conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment or by an entity or individual approved by the commissioner, or is directed in a specific instance to use an epinephrine [auto-injector] injector device by a health care practitioner. The training required by this paragraph shall include (i) how to recognize signs and symptoms of severe allergic reactions, including anaphylaxis; (ii) recommended dosage for adults and children; (iii) standards and procedures for the storage and administration of an epinephrine [auto-injector] injector; and (iv) emergency follow-up procedures.

(d) This section does not prohibit the use of an epinephrine [auto-injector] injector device (i) by a health care practitioner or (ii) by a person acting pursuant to a lawful patient-specific prescription.

(e) Every eligible person and entity authorized to possess and use epinephrine [auto-injector] injector devices pursuant to this section shall use, maintain and dispose of such devices pursuant to regulations of the department.

(f) Nothing in this section shall require any eligible person or entity to acquire, possess, store, make available, or administer an epinephrine [auto-injector] injector.

3. Prescriptions. (a) A health care practitioner who is authorized to prescribe drugs may prescribe, dispense or provide an epinephrine [autoinjector] injector device to or for an eligible person or entity by a non-patient-specific prescription.

(b) A pharmacist may dispense an epinephrine [auto-injector] injector pursuant to a non-patient-specific prescription under this subdivision.

(c) This subdivision does not limit any other authority a health care practitioner or pharmacist has to prescribe, dispense, provide or administer an epinephrine [auto-injector] injector device.

4. Application of other laws. (a) Use of an epinephrine [auto-injector] injector device pursuant to this section shall be considered first

S. 2537 3

aid or emergency treatment for the purpose of any statute relating to liability.

(b) Purchase, acquisition, possession or use of an epinephrine [autoinjector] injector device pursuant to this section shall not constitute the unlawful practice of a profession or other violation under title eight of the education law or article thirty-three of this chapter.

(c) Any person otherwise authorized to sell or provide an epinephrine [auto-injector] injector device may sell or provide it to a person or entity authorized to possess it pursuant to this section.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to epinephrine injec- tor devices

Purpose or general idea of the bill

This legislation will help increase access to epinephrine devices by permitting the use of additional FDA-approved epinephrine delivery devices including prefilled syringes.

Summary of provisions

Section 1 of the bill amends public health law section 3000-c to replace "auto-injector" devices with "injector" devices in order to authorize the use of additional FDA-approved epinephrine injector delivery devices.

Section 2 is the effective date.

Justification

Today, 1 in 50 Americans are at risk for anaphylaxis - a severe allergic reaction that can lead to death. While New York has been a leader in protecting those who suffer from severe allergic reactions by increasing access to epinephrine in an emergency, making it available in more plac- es, and by authorizing its administration by more individuals - more can and should be done.

In 2014, this section of the Public Health Law was amended to authorize schools to stock and administer epinephrine in an emergency. In 2016, this section was further amended to authorize facilities such as day care centers, and sports arenas and camps, to stock and administer this life-saving medication in an emergency. These changes are of importance as severe allergic reactions can occur anywhere and at any time. These changes have helped save lives and better protect children and adults with severe allergies. While well intentioned, the current law limits the types of epinephrine devices that may be used to auto-injector devices. Over the years, this has led to shortages, limiting the avail- ability to this life-saving medication, as well as astronomical price increases for these auto-injector devices.

This legislation will help ensure patient access to affordable, life- saving medication by authorizing the use of all epinephrine injector devices approved by the Food and Drug Administration (FDA). We need to remove whatever barriers we can to ensure children and adults have access to the life-saving medication they need. This bill does just that by authorizing the use of all FDA-approved epinephrine injector devices including prefilled syringes and future FDA-approved delivery systems.

Prior legislative history

2019-2020: S8308/A9964 Abinati

Fiscal implications for state and local governments

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.